LMG Life Sciences Awards EMEA 2022: open for submissions

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

LMG Life Sciences Awards EMEA 2022: open for submissions

lmg-life-sciences-awards-for-dat-600x400-emea.png

The EMEA region research cycle has commenced – do not miss the opportunity to nominate your work from 2021

The LMG Life Sciences Awards team is excited to announce the launch of the 2022 research. You can find more about the awards, including the methodology, FAQs, and the full list of categories at the LMG Life Sciences website.

2022 calendar:

  • Research launches: December 9 2021

  • Submissions deadline: January 27 2022

  • Research interviews: February 1 to March 18 2022

  • Awards ceremony: May 12 2022

All submissions must be uploaded here by January 27 2022.

For any questions about the awards or the research, please contact the lead researcher, John Harrison.

For queries about business development and commercial opportunities related to the awards, please contact Nick Heath.

Last year’s LMG Life Sciences Awards winners’ presentation and lists are free to view at Winners 2021.

Good luck to everyone!

more from across site and SHARED ros bottom lb

More from across our site

The team, comprising two partners and one senior consultant, plans to offer “highly differentiated” services to clients
HGF’s new ownership model frees it from the hiring constraints of traditional partnerships, its CEO told Managing IP
New timeline for 2026 aims to provide clearer guidance to firms and practitioners on the full jurisdictional market view
Attorneys contemplate whether clients using AI for legal guidance is beneficial to attorney-client relationships or more of a nuisance
Richard de Bodo, who had a lengthy career at international firms, shares how he will address client needs and praises the unique offerings of smaller firms
An Australian top court decision clarifying honest concurrent use and wins by publishers against AI platforms were also among the top talking points
AIPPI has pulled the plug on its planned 2027 World Congress, and INTA has delayed hosting a meeting there, but the concerns won’t abate
Despite being outspent by a wealthy opponent, a trial attorney at King & Spalding says ‘relentless pursuit of the truth’ helped his team secure a $420m damages award for mobile gaming client
190 drugs face loss of exclusivity between 2026 and 2030, with the list including Bristol Myers Squibb’s blood-thinning drug Eliquis and immunotherapy medication Opdivo
Nokia, represented by a team from Bird & Bird, adjudged to have made fair offer to Asus and Acer in UK SEP dispute
Gift this article